Correlation Between Vanguard Tax-managed and Keros Therapeutics
Can any of the company-specific risk be diversified away by investing in both Vanguard Tax-managed and Keros Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vanguard Tax-managed and Keros Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vanguard Tax Managed Capital and Keros Therapeutics, you can compare the effects of market volatilities on Vanguard Tax-managed and Keros Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vanguard Tax-managed with a short position of Keros Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vanguard Tax-managed and Keros Therapeutics.
Diversification Opportunities for Vanguard Tax-managed and Keros Therapeutics
-0.4 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Vanguard and Keros is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding Vanguard Tax Managed Capital and Keros Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Keros Therapeutics and Vanguard Tax-managed is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vanguard Tax Managed Capital are associated (or correlated) with Keros Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Keros Therapeutics has no effect on the direction of Vanguard Tax-managed i.e., Vanguard Tax-managed and Keros Therapeutics go up and down completely randomly.
Pair Corralation between Vanguard Tax-managed and Keros Therapeutics
Assuming the 90 days horizon Vanguard Tax-managed is expected to generate 2.41 times less return on investment than Keros Therapeutics. But when comparing it to its historical volatility, Vanguard Tax Managed Capital is 3.5 times less risky than Keros Therapeutics. It trades about 0.07 of its potential returns per unit of risk. Keros Therapeutics is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 2,737 in Keros Therapeutics on March 16, 2024 and sell it today you would earn a total of 2,213 from holding Keros Therapeutics or generate 80.85% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Vanguard Tax Managed Capital vs. Keros Therapeutics
Performance |
Timeline |
Vanguard Tax Managed |
Keros Therapeutics |
Vanguard Tax-managed and Keros Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Vanguard Tax-managed and Keros Therapeutics
The main advantage of trading using opposite Vanguard Tax-managed and Keros Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vanguard Tax-managed position performs unexpectedly, Keros Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Keros Therapeutics will offset losses from the drop in Keros Therapeutics' long position.Vanguard Tax-managed vs. Vanguard Total Bond | Vanguard Tax-managed vs. Vanguard Small Cap Index | Vanguard Tax-managed vs. Vanguard Mid Cap Index | Vanguard Tax-managed vs. Vanguard Extended Market |
Keros Therapeutics vs. Eliem Therapeutics | Keros Therapeutics vs. Anebulo Pharmaceuticals | Keros Therapeutics vs. Monte Rosa Therapeutics | Keros Therapeutics vs. Edgewise Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Complementary Tools
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |